Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Rapid Dengue Test

Rapid Dengue Test A new test for the dengue virus may help public health laboratories identify infected individuals more rapidly, according to the US Centers for Disease Control and Prevention, which developed the test. Thousands of cases of dengue are reported in the United States each year, primarily in individuals who have traveled to regions of the world where the virus is endemic. Patients infected with the virus may develop a high fever, severe headache, and pain. Some may develop life-threatening hemorrhage and shock. Public health laboratories currently test for certain antibodies. But patients may not develop such antibodies until 4 to 7 days after they become ill, so the test may not identify the infection during its early stages, when treatment can be most effective. The new CDC DENV-1-4 Real-Time RT-PCR Assay, which has been approved by the US Food and Drug Administration, tests for the presence of the virus and may identify infections more quickly. Test kits were expected to become available July 2. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Rapid Dengue Test

JAMA , Volume 308 (4) – Jul 25, 2012

Rapid Dengue Test

Abstract

A new test for the dengue virus may help public health laboratories identify infected individuals more rapidly, according to the US Centers for Disease Control and Prevention, which developed the test. Thousands of cases of dengue are reported in the United States each year, primarily in individuals who have traveled to regions of the world where the virus is endemic. Patients infected with the virus may develop a high fever, severe headache, and pain. Some may develop life-threatening...
Loading next page...
 
/lp/american-medical-association/rapid-dengue-test-tfKM7eeM6o
Publisher
American Medical Association
Copyright
Copyright © 2012 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2012.8756
Publisher site
See Article on Publisher Site

Abstract

A new test for the dengue virus may help public health laboratories identify infected individuals more rapidly, according to the US Centers for Disease Control and Prevention, which developed the test. Thousands of cases of dengue are reported in the United States each year, primarily in individuals who have traveled to regions of the world where the virus is endemic. Patients infected with the virus may develop a high fever, severe headache, and pain. Some may develop life-threatening hemorrhage and shock. Public health laboratories currently test for certain antibodies. But patients may not develop such antibodies until 4 to 7 days after they become ill, so the test may not identify the infection during its early stages, when treatment can be most effective. The new CDC DENV-1-4 Real-Time RT-PCR Assay, which has been approved by the US Food and Drug Administration, tests for the presence of the virus and may identify infections more quickly. Test kits were expected to become available July 2.

Journal

JAMAAmerican Medical Association

Published: Jul 25, 2012

Keywords: dengue fever

There are no references for this article.